Citations (8)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Jared A Cohen & Armin Ghobadi. (2022) Axicabtagene ciloleucel for the treatment of relapsed or refractory follicular lymphoma. Expert Review of Anticancer Therapy 22:9, pages 903-914.
Read now
Read now
Jennifer Kelly Anderson & Amitkumar Mehta. (2019) A review of chimeric antigen receptor T-cells in lymphoma. Expert Review of Hematology 12:7, pages 551-561.
Read now
Read now
Laura Kuhlmann, Emma Cummins, Ismael Samudio & Thomas Kislinger. (2018) Cell-surface proteomics for the identification of novel therapeutic targets in cancer. Expert Review of Proteomics 15:3, pages 259-275.
Read now
Read now
Articles from other publishers (5)
Alexander Shimabukuro-Vornhagen, Philipp Gödel, Marion Subklewe, Hans Joachim Stemmler, Hans Anton Schlößer, Max Schlaak, Matthias Kochanek, Boris Böll & Michael S. von Bergwelt-Baildon. (2018) Cytokine release syndrome. Journal for ImmunoTherapy of Cancer 6:1.
Crossref
Crossref
Thomas D. Rodgers & Paul M. Barr. (2018) Pitfalls of Combining Novel Agents in Lymphoma. Current Treatment Options in Oncology 19:7.
Crossref
Crossref
Samaresh Sau, Hashem O. Alsaab, Ketki Bhise, Rami Alzhrani, Ghazal Nabil & Arun K. Iyer. (2018) Multifunctional nanoparticles for cancer immunotherapy: A groundbreaking approach for reprogramming malfunctioned tumor environment. Journal of Controlled Release 274, pages 24-34.
Crossref
Crossref
Sujan K. Dhar & Manjula Das. (2018) Engineering Antibodies. Journal of the Indian Institute of Science 98:1, pages 5-20.
Crossref
Crossref
Wei-Wei ZhangLongjiang LiDinggang LiJiliang LiuXiuqin LiWei LiXiaolong XuMichael J. ZhangLois A. ChandlerHong LinAiguo HuWei XuDominic Man-Kit Lam. (2018)
The First Approved Gene Therapy Product for Cancer Ad-
p53
(Gendicine): 12 Years in the Clinic
. Human Gene Therapy 29:2, pages 160-179.
Crossref
Crossref